1. Home
  2. IMRN vs LSH Comparison

IMRN vs LSH Comparison

Compare IMRN & LSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • LSH
  • Stock Information
  • Founded
  • IMRN 1994
  • LSH 2018
  • Country
  • IMRN Australia
  • LSH United States
  • Employees
  • IMRN N/A
  • LSH N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • LSH
  • Sector
  • IMRN Health Care
  • LSH
  • Exchange
  • IMRN Nasdaq
  • LSH NYSE
  • Market Cap
  • IMRN 9.2M
  • LSH 9.4M
  • IPO Year
  • IMRN N/A
  • LSH 2024
  • Fundamental
  • Price
  • IMRN $1.72
  • LSH $0.84
  • Analyst Decision
  • IMRN Strong Buy
  • LSH
  • Analyst Count
  • IMRN 1
  • LSH 0
  • Target Price
  • IMRN $5.00
  • LSH N/A
  • AVG Volume (30 Days)
  • IMRN 656.2K
  • LSH 14.4K
  • Earning Date
  • IMRN 09-08-2025
  • LSH 08-05-2025
  • Dividend Yield
  • IMRN N/A
  • LSH N/A
  • EPS Growth
  • IMRN N/A
  • LSH N/A
  • EPS
  • IMRN N/A
  • LSH N/A
  • Revenue
  • IMRN $4,048,286.00
  • LSH $16,270,095.00
  • Revenue This Year
  • IMRN N/A
  • LSH N/A
  • Revenue Next Year
  • IMRN N/A
  • LSH N/A
  • P/E Ratio
  • IMRN N/A
  • LSH N/A
  • Revenue Growth
  • IMRN 82.90
  • LSH N/A
  • 52 Week Low
  • IMRN $1.50
  • LSH $0.82
  • 52 Week High
  • IMRN $2.87
  • LSH $4.34
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 45.31
  • LSH N/A
  • Support Level
  • IMRN $1.60
  • LSH N/A
  • Resistance Level
  • IMRN $1.80
  • LSH N/A
  • Average True Range (ATR)
  • IMRN 0.10
  • LSH 0.00
  • MACD
  • IMRN -0.01
  • LSH 0.00
  • Stochastic Oscillator
  • IMRN 34.09
  • LSH 0.00

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About LSH LAKESIDE HOLDING LTD

Lakeside Holding Ltd i an integrated cross-border supply chain solution provider with a strategic focus on the Asian market including China and South Korea. It provides customized cross-border ocean freight solutions and airfreight solutions in the U.S, including cross-border freight consolidation and forwarding services; customs clearance services; warehousing and distribution services and U.S. domestic ground transportation services.

Share on Social Networks: